United Nations Office for Project Services (HQ)

Clave 010.000.5551.00: Dabigatrán Etexilato; Clave 010.000.5551.01: Dabigatrán Etexilato; Clave 010.000.5552.00: Dabigatrán Etexilato; Clave 010.000.5552.01: Dabigatrán Etexilato; Clave 010.000.5935.00: Dabigatrán; Clave 010.000.6009.00: Empagliflozina; Clave 010.000.6068.00: Nintedanib; Clave 010.000.6149.00: Afatinib; Clave 010.000.6224.00: Afatinib

Last update: Mar 25, 2021 Last update: Mar 25, 2021

Details

Locations:Mexico
Start Date:Dec, 2020
End Date:Unknown
Contract value: USD 18,211,833
Sectors:Health
Health
Categories:Goods
Date posted:Mar 25, 2021

Associated funding

Associated experts

Description

Title: UNOPS/MX/SO/0008-2020

Reference: Medicamento de Patentes

Description: Clave 010.000.5551.00: Dabigatrán Etexilato.

Clave 010.000.5551.01: Dabigatrán Etexilato.

Clave 010.000.5552.00: Dabigatrán Etexilato.

Clave 010.000.5552.01: Dabigatrán Etexilato.

Clave 010.000.5935.00: Dabigatrán.

Clave 010.000.6009.00: Empagliflozina.  

Clave 010.000.6068.00: Nintedanib.

Clave 010.000.6149.00: Afatinib.

Clave 010.000.6224.00: Afatinib.

El contrato fue generado y firmado por el contratista en pesos mexicanos (MXN) por un monto de: 363,326,107.55

 

Want to unlock full information?
Member-only information. Become a member to access projects awards, find the right consortia partners, subcontractors and more.